Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Losmapimod dru. Show all posts
Showing posts with label Losmapimod dru. Show all posts
Wednesday, June 22, 2016

Losmapimod drug fails to meet primary endpoint in clinical trial

›
Patients taking losmapimod, an anti-inflammatory drug currently being developed, for 12 weeks following a heart attack did not sho...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.